Craig Arnott is Deputy Chief Investment Officer, and a member of Burford’s Management and Commitments, with responsibility across Burford’s investment portfolio. In this capacity, he helps lead Burford’s review and management of our global portfolio.
Prior to joining Burford, Mr. Arnott advised the company while serving as barrister at Sixth Floor Selborne and Wentworth Chambers in Sydney. Before being called to the Bar, he was a Partner and Head of Competition/Antitrust Law in London at the international firm Fried Frank. During his time at Fried Frank, Mr. Arnott oversaw many significant deals, including serving as counsel to the pharmaceuticals company Merck in its acquisition of Schering-Plough and as European Counsel to Delta & Pine Land during its acquisition by Monsanto. Mr. Arnott was a litigator at Cravath, Swaine & Moore in New York, Gilbert and Tobin in Sydney and Ashurst in London.